Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $159.26 Analyst target: $154.80 Upside: -2.80%
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
See the full interactive analysis & chart →Informational only — not investment advice.